Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (Text with EEA relevance.)
Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (Text with EEA relevance.)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Supplementary provisions
ANNEXSupplementary provisions
ANNEX Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 4, Azoxystrobin, the date is replaced by ‘31 December 2024’; (2) in the sixth column, expiration of approval, of row 5, Imazalil, the date is replaced by ‘31 December 2024’; (3) in the sixth column, expiration of approval, of row 6, Prohexadione, the date is replaced by ‘31 December 2022’ (4) in the sixth column, expiration of approval, of row 7, Spiroxamine, the date is replaced by ‘31 December 2023’; (5) in the sixth column, expiration of approval, of row 8, Kresoxim-methyl, the date is replaced by ‘31 December 2024’; (6) in the sixth column, expiration of approval, of row 9, Fluroxypyr, the date is replaced by ‘31 December 2024’; (7) in the sixth column, expiration of approval, of row 10, Tefluthrin, the date is replaced by ‘31 December 2024’; (8) in the sixth column, expiration of approval, of row 11, Oxyfluorfen, the date is replaced by ‘31 December 2024’; (9) in the sixth column, expiration of approval, of row 12, 1-naphthylacetamide, the date is replaced by ‘31 December 2023’; (10) in the sixth column, expiration of approval, of row 13, 1-naphthylacetic acid, the date is replaced by ‘31 December 2023’; (11) in the sixth column, expiration of approval, of row 15, Fluazifop P, the date is replaced by ‘31 December 2023’; (12) in the sixth column, expiration of approval, of row 16, Terbuthylazine, the date is replaced by ‘31 December 2024’; (13) in the sixth column, expiration of approval, of row 19, Acrinathrin, the date is replaced by ‘31 December 2023’; (14) in the sixth column, expiration of approval, of row 20, Prochloraz, the date is replaced by ‘31 December 2023’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview